Many patients may keep off lost pounds after stopping a GLP-1, US data suggests
Real-world data suggests weight loss durability post-GLP-1 drug discontinuationStudy suggests weight regain may be less common than clinical…
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalledTzield pushed back after adverse event…
US FDA requests removal of suicide warnings from weight-loss drug labels
Regulator asks drugmakers to remove warnings of suicidal thoughts from GLP-1 drugs’ labelsFDA finds no link between GLP-1…
J&J strikes deal with US government to cut drug prices, gain tariff exemptions
Jan 8 (Reuters) – Johnson & Johnson (JNJ.N), opens new tab said on Thursday that it has reached…
Qatar and UAE to join U.S.-led effort to bolster technology supply chain
Qatar and UAE to officially join ‘Pax Silica’ within daysInitiative aims to move the Middle East toward a…
Schrodinger to offer Eli Lilly’s AI drug discovery platform on its software
Jan 9 (Reuters) – Schrodinger (SDGR.O), opens new tab said on Friday it is collaborating with Eli Lilly…
TPG in talks to buy UnitedHealth’s Optum UK unit, Sky News reports
Jan 6 (Reuters) – U.S. private equity firm TPG (TPG.O), opens new tab is close to acquiring UnitedHealth’s…
Trump says he will meet with health insurers ‘in a few days’
WASHINGTON, Jan 6 (Reuters) – U.S. President Donald Trump said on Tuesday he would meet with representatives from…
US CDC says 2025-26 flu season ‘moderately severe’ as cases hit 11 million
Item 1 of 2 A sign advertises flu, pneumonia, and shingles vaccine shots at a Walgreens pharmacy in…
US FDA approves Vanda Pharmaceuticals’ motion sickness drug
Dec 30 (Reuters) – Vanda Pharmaceuticals (VNDA.O), opens new tab said on Tuesday its drug for the prevention…
European shares close at fresh record high as Novo Nordisk drives healthcare boost
Euro zone equity volatility at over a year-lowHealthcare stocks top gainers after Novo Nordisk boostBasic resources gain on…